Genomic testing enables personalized prostate cancer treatment, but disparities in access persist, highlighting the need for equitable policies ensuring all patients benefit from precision medicine advances.

Safely reducing broad-spectrum antibiotics in improving sepsis patients may curb resistance, lower side effects, and maintain recovery, prompting hospitals to rethink antibiotic de-escalation practices nationwide.

Breast cancer patients receiving neoadjuvant therapy show changing quality-of-life needs, emphasizing personalized emotional support to improve wellbeing, treatment adherence, and overall outcomes throughout care.

Treatment-resistant postpartum depression leaves some mothers without relief, highlighting urgent needs for identifying risk factors, personalized care, and better support to improve recovery for families.

Many commercially insured Americans live with chronic conditions, driving higher healthcare costs and underscoring the need for improved prevention, management strategies, and informed policy decisions.

Navigating mental health services is increasingly vital as anxiety and depression rise, helping individuals overcome access barriers, find timely care, and connect with support resources.

Chlamydia, the world’s most common bacterial STI, disproportionately affects young women in South Africa, underscoring urgent needs for targeted screening, education, prevention, and treatment access.

Evaluating evidence behind depression therapies, including interpersonal therapy, CBT, and medication, is crucial to ensure trustworthy research guides treatment choices for patients, clinicians, and policymakers.

A nasal spray vaccine shows promise against bird flu, potentially blocking H5N1 infections, reducing transmission, and strengthening pandemic preparedness beyond traditional influenza shots.

EMA and remote measurement-based care use technology to monitor mental health in real time, enabling more personalized treatment, better outcomes, and improved patient engagement.